Dr. Rebecca L. Shpall, MD

Dr. Shpall practices at Palo Alto Medical Foundation-Fremont Center in Fremont, California.

Dr. Shpall's NPI, 1043386527, was assigned on November 28, 2006. Dr. Shpall graduated from UC Irvine School of Medicine in 2003. Dr. Shpall holds California license A88345.

Dr. Shpall's primary practice is Palo Alto Medical Foundation-Fremont Center, at 3200 Kearney Street, Fremont, CA 94538. The practice phone is (510) 498-2812.

Dr. Shpall's primary practice is Palo Alto Medical Foundation-Fremont Center in Fremont, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Shpall to 1 more group practice or clinic, named with a free account. Dr. Shpall's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shpall practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Shpall's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Shpall is board certified in dermatology by the American Board of Dermatology. Dr. Shpall is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Shpall treats.

CMS data shows 2,150 Medicare services from Dr. Shpall across 13 procedure codes in 2024, for 603 Medicare patients. Medicare paid $132,453 for them. Every service was in an office.

CMS counts 603 Medicare patients who saw Dr. Shpall in 2024. The largest group is 65 to 74, with 297 patients. 71% of them have high cholesterol, and 59% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shpall's median patient age at 51, with 59% women.

In 2024, Dr. Shpall wrote 916 Medicare Part D claims for 339 patients. 91% of them were for generic drugs. CMS names the drug for 747 of them, across 17 drugs with 11 or more claims each, at $201,973 in total drug cost. In 2023, CMS named 638 claims across 15 drugs.

Dr. Shpall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shpall as offering telehealth. CMS counts 662 procedures of removal of skin lesions by Dr. Shpall, more than 89% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Shpall. The most frequent topics are Carrier Proteins, Intracellular Signaling Peptides and Proteins and Subcellular Fractions. Dr. Shpall has published most often in J Interferon Cytokine Res. Dr. Shpall's most frequent co-author is Nina C. Botto, MD.

CMS Open Payments shows 3 general payments to Dr. Shpall from 3 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 75% of the total. Arcutis Biotherapeutics, Inc. paid the most, $24.

Dmand AI lists 2 awards for Dr. Shpall, most recently CMS Stage 1 EHR in 2013.

Dr. Shpall graduated from UC Irvine School of Medicine in 2003. Dr. Shpall is a member of AAD.

Dr. Shpall is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.